EuroMov

What EuroMov does

EuroMov DHM (Digital Health in Motion) is a French academic research laboratory classified as a Unité Mixte de Recherche (UMR), focused on the computational understanding of human sensorimotor plasticity and its applications to digital health, rehabilitation, and human-machine interaction. The unit was formed through the 2021 merger of EA 2991 (EuroMov) and UPR IMT (LGI2P) and operates jointly under IMT Mines Alès and the University of Montpellier. Its research program is organized around three scientific themes (LAC — Learning and Complexity; MIB — Monitoring and Improving Behaviors; PIAS — Perception in Action and Synchronization) and two transverse axes (SemTAXM and Factory). Applied projects include BeatPark (a mobile Parkinson's gait rehabilitation app using adaptive auditory cueing based on a locomotor oscillator model), ReArm (HD-tDCS combined with virtual reality therapy for chronic stroke recovery), MOVCAP (drone-based sports motion capture for ecological kinematic data acquisition), and SHARESPACE (a European XR project on shared hybrid spaces).

The lab's commercial activity is structured as technology transfer rather than product sales. Revenue derives from public research funding (EU FP7 and Horizon Europe grants, ANR, institutional support from IMT Mines Alès and the University of Montpellier), clinical trial partnerships with regional university hospitals (CHU Montpellier, CHU Nîmes, Clinique Beau Soleil), corporate sponsorship (Air Liquide for BeatPark), and technology transfer through SATT AXLR and the IMT Mines Alès incubator, which has spawned spin-offs such as Semaxone. No commercial pricing or product distribution channels are disclosed, and the lab's counterparties are institutional research and clinical partners rather than commercial buyers.

Technically, the lab combines symbolic and connectionist AI with movement science, neuroscience, and clinical research. Core technical components include motion capture systems, brain-machine interfaces, virtual reality therapy platforms, adaptive auditory stimulation algorithms, and machine learning applied to wearable time-series data for behavior characterization and fatigue monitoring. Distribution is essentially nil on a commercial basis; research outputs are disseminated through scientific publications, conferences, seminars, and journal clubs, with patient reach achieved indirectly through the multi-site BeatPark clinical trial spanning 17 centers in France.

Name

EuroMov

Legal name

EuroMov Digital Health in Motion

Website

https://euromov.eu

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

51–100 employees

Short description

EuroMov DHM is a French academic research laboratory (UMR) under IMT Mines Alès and University of Montpellier, conducting interdisciplinary research on human movement, sensorimotor plasticity, and AI, with applied projects in rehabilitation and motion capture.

Ownership category

akta.pro rank

Product category

Medical and Digital Health Research

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK)

akta.pro secondary industries

Neurology RPM (epilepsy, Parkinson’s, MS monitoring) (HLALAFAJ), Decentralized/Hybrid Trial Enablement (DCT) Platforms (HLACAOAL)

Keywords

• Human movement research
• Digital health technology
• Neural rehabilitation studies
• Motion capture systems
• Sensorimotor plasticity

Headquarters

HQ city

Montpellier

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Research Funding: Primary revenue from public research funding including European Union grants (FP7, Horizon Europe), French National Research Agency (ANR), and institutional support from parent organizations IMT Mines Alès and University of Montpellier.
2. Clinical Trial Partnerships: Revenue from clinical trial collaborations with healthcare institutions including CHU Montpellier, CHU Nîmes, and Clinique Beau Soleil.
3. Technology Transfer: Commercialization of research outcomes through technology transfer via SATT AXLR and the IMT Mines Alès incubator, supporting spin-off companies like Semaxone.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

EuroMov DHM is a French academic research laboratory that conducts interdisciplinary research on human movement, sensorimotor plasticity, and digital health, combining movement science, neuroscience, clinical research, and artificial intelligence. It develops applied research projects such as the BeatPark mobile application for Parkinson's gait rehabilitation, ReArm for combined HD-tDCS and virtual reality stroke therapy, MOVCAP for drone-based sports motion capture, and SHARESPACE for extended reality social interaction, while partnering with hospitals for clinical validation.

Product overview

EuroMov DHM is a research laboratory structured around three scientific themes (LAC: Learning and Complexity; MIB: Monitoring and Improving Behaviors; PIAS: Perception in Action and Synchronization) and two transverse axes (SemTAXM: Semantics and Taxonomy of Movement; Factory: methodological support). The portfolio includes applied research projects: BeatPark, a mobile application for Parkinson's gait rehabilitation; ReArm, a clinical study combining HD-tDCS with virtual reality for stroke recovery; MOVCAP, a drone-based motion capture research tool; and SHARESPACE, an extended reality social interaction project.

Differentiator

Problem solved

Functional benefit

Brands

• BeatPark: A mobile musical application designed for the rehabilitation of patients suffering from Parkinson disease, combining pleasurable music experience with gait reeducation.
• ReArm
• MOVCAP

Products and services

• BeatPark Mobile musical application for gait rehabilitation of Parkinson's disease patients using adaptive auditory cueing. Remote sensors capture footsteps and wirelessly connect to a smartphone to deliver musical beats synchronized to the patient's walking rhythm, based on the locomotor oscillator model. Aimed at clinical use for Parkinson's disease rehabilitation.
• ReArm Clinical research study combining high-definition transcranial direct current stimulation (HD-tDCS) with virtual reality therapy for functional recovery of arm function in chronic stroke patients. Integrates clinical sciences, brain sciences (EEG, fNIRS), and data sciences to predict clinical efficiency patient-by-patient through multi-criteria decision analysis.
• MOVCAP Mobile sports motion capture system using drone-based optical measurement for continuous, reliable, and reproducible kinematic data acquisition of sporting gestures under ecological (real-world) conditions. Developed in partnership with GAMBI-M and LIRMM for sports medicine and athlete fatigue monitoring.
• SHARESPACE European project (HORIZON-CL4-2022-HUMAN-01-14, running 2023-2025) developing eXtended Reality (XR) technology for promoting ethical and social interaction in shared hybrid spaces, anchored in human sensorimotor communication primitives. EuroMov DHM serves as a research partner.

Quantifiable outcome

• BeatPark clinical trial with 396 patients across 17 centers
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature5 records

Partnerships

Twelve partnerships are on record, tiered core, major and minor.

• IMT Mines AlèscoreStrategic or Co-development PartnerPrimary institutional partner providing research facilities, managerial and economic support through its incubator, and educational resources. The lab's facilities contribute to training and educational exercises of both institutions.
• University of MontpelliercoreStrategic or Co-development PartnerPrimary institutional partner providing research facilities and academic framework. Contributes to training and educational exercises alongside IMT Mines Alès.
• CHU MontpelliercoreStrategic or Co-development PartnerUniversity hospital center partnership for clinical research, patient recruitment, and clinical validation studies.
• CHU NîmesmajorStrategic or Co-development PartnerUniversity hospital center partnership for clinical research collaboration and patient studies.
• Clinique Beau SoleilmajorStrategic or Co-development PartnerClinical partner coordinating the BeatPark rehabilitation program clinical trial with 396 patients across 17 centers in France.
• KorianminorStrategic or Co-development PartnerHealthcare provider partner in the EuroMov ecosystem for potential clinical applications of research outcomes.
• SATT AXLRmajorTechnology or IntegrationTechnology transfer society supporting the industrialization and commercialization of research outcomes from BeatPark clinical trials.
• France ParkinsonmajorStrategic or Co-development PartnerPatient organization supporting the BeatPark rehabilitation program through patient network and advocacy.
• LIRMMcoreTechnology or IntegrationLaboratoire d'Informatique, de Robotique et de Microélectronique de Montpellier - research laboratory partner for MOVCAP project, contributing robotic, computer, and mathematical expertise.
• GAMBI-MmajorTechnology or IntegrationYoung innovative company partner for the MOVCAP mobile motion capture project, contributing industry expertise.
• DiappyMedminorStrategic or Co-development PartnerStartup specializing in digital therapies for diabetes, hosting EuroMov researchers for industry experience (Data Engineer position).
• SemaxoneminorStrategic or Co-development PartnerDeep-tech company conducting R&D in augmented cognition and neurofeedback for humans in complex environments, laureate of the MUSE Companies on Campus project.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Saebo: Developer of orthoses and rehabilitation technology for stroke survivors; directly comparable to EuroMov's ReArm upper-limb neurorehabilitation research.
• Hocoma (part of DIH Medical): Swiss-headquartered maker of robotic and sensor-based rehabilitation devices for gait, balance, and arm therapy; closely comparable to EuroMov's rehabilitation-technology focus.
• Xsens (Movella): 3D motion capture and inertial sensor technology provider widely used for human movement analysis in sports, rehab, and research; comparable to EuroMov's wearable/IMU-based motion capture work.
• MedRhythms: Digital therapeutics company focused on neurologically-based walking rehabilitation using rhythmic auditory stimulation; directly comparable to EuroMov's BeatPark program for Parkinson's gait retraining.
• Bertec Corporation: Developer of balance, gait, and human-movement measurement instruments for clinical and sports applications; comparable to EuroMov's motion-capture and sports-performance research (MOVCAP).
• MindMaze: Digital neurotherapeutics platform combining AI, motion capture, brain-computer interfaces, and VR for stroke and brain injury recovery; closely comparable to EuroMov's ReArm and SHARESPACE programs.

Regional players

• Sensorion: French biotech developing therapies for hearing, vertigo, and inner-ear disorders; regionally comparable as a French-listed neuroscience/clinical development company, though targeting a different therapeutic area.
• Wandercraft: French developer of self-balanced exoskeletons for gait rehabilitation of stroke and spinal cord injury patients; comparable French-based company working on mobility-restoration technology with similar end users to EuroMov's clinical programs.

Others

• Inria (French National Institute for Research in Digital Science and Technology): French public research institute running interdisciplinary digital-science labs in AI, robotics, and biomedical engineering; comparable public-research context and AI/neuroscience overlap, though not a direct commercial peer.
• CEA (French Alternative Energies and Atomic Energy Commission) - Clinatec: French public biomedical research center focused on neurotechnologies, brain-computer interfaces, and rehabilitation engineering; comparable institutional peer with overlapping BCIs and clinical rehabilitation focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/EuroMov?s=20
• Facebookfacebook.com/EuroMov

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EuroMov